In Finland, more than 300 out of 550 pharmacies are using a computer-based drug information system, ELLI. The system is integrated with the software program which the pharmacies use to process prescriptions during dispensing. The ELLI system generates leaflets, which include information of the effects, adverse effects and the proper use of the medicine.
covers most prescription drugs available in Finland and is continuously updated. ELLI is also available for physicians" desk reference programs and as a separate PC version.
The instructions have been written by a group of physicians and reviewed by an advisory panel consisting of experts in medicine and pharmacy. As Finland has two official languages, the text may be printed either in Finnish or Swedish.
The text consists of sections which may be common for several drugs or drug presentations. For instance, all bets-blocking agents share the same text on adverse reactions and all enteric-coated tablets and capsules are advised to swallow whole.
The electronically produced patient information leaflets have several advantages compared with the conventional printed material. The leaflets are easy and quick to produce and they need no storage space. The information is updated frequently.
Patients have been content with the system and the leaflets has been judged to be easy to read and understand. According to the recent study, the ELLI leaflets can be a remarkable aid in increasing the patients' knowledge of their medicationL 1. S. Peura, T. Klaukka, A-M. Hannula, S. Eerik~iinen. Electronically produced information leaflets increase patients' understanding about antibiotics. The International Journal of Pharmacy Practice (in press).
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PHARMACIST INVOLVEMENT IN PATIENT DRUG INFORMATION
~o]~h~ Dot P. Brnring
In 1988 a group of 170 Dutch community pharmacists, all users of a Pharmacom computerized pharmacy automation system, expressed their feelings about the needs of adequate written patient information by writing leaflets in lay language for all products that could be handed over at the counter. At that time only 50% of the delivered medicines contained a patient package insert (PPI) of industrial origin. Additional leaflets, brochures or photocopies were available for 20%. In 1992 this has been greatly improved and most industries did put great effort in designing PPIs.
However, we still think that our patient-information-leaflets have advantages. The key,word is "individualisation". It is possible to generate drug information during filling prescriptions that is directly related to individual circumstances. Individualized "blocks" of information are printed for instructions and warnings related to concomitant use of interacting drugs. It is possible to give individualized information in cases of double medication (about risks of simultaneous ~ of drugs belonging to the same pharmacotherapeutic class) and in cases of a different daily dosage as compared with the previous delivery of the same drug. In the near future the texts will be individualized according to age and gender and it will be possible to generate leaflets in different languages.
In our belief, this all means only an small step in the right direction. Informing the patient, in a way he/she is fully aware of benefits and risks of medication and is likely to act according to the directions of use, needs more than handing out a leaflet.
Patient counselling by the pharmacist as well as the physician reinforces written information. Pharmacists and physicians (and their assistants) should cooperate in providing the patient with like-worded information. They should also create an atmosphere in which patient counselling is being asked for by the patient.
Health Base Foundation, Van Eedenstraat 7, 2012 EL Haarlem, The Netherlands.
ASSESSING ELDERLY PATIENTS KNOWLEDGE OF THEIR MEDICATIONS AND IDENTIFYING STRATEGIES FOR INTERVENTION
J.A_ Coorrlbe, S~ R. Home There is strong evidence that patients require more information about medications t . Knowledge about medications is thought to facilitate safe and appropriate use of medicine and improve adherence 2.
Medication knowledge was assessed during hospital stay and two weeks post discharge using a questionnaire, designed and piloted for use in this study. Sixty-four patients were interviewed on the 'Care of the Elderly Unit' and thirty-eight were followed up in their homes.
Knowledge about dosing frequency was good, but there were major deficits in knowledge about indication, length of treatment, side effects, and drug name in all groups.
Comparison of the thirty-eight patients before and after discharge showed that a stay in hospital did not improve patients knowledge of medication.
These results were used to draw up a check list for pharmaceutical care including giving patients individualised information about their medications.
PATIENT EDUCATION IN COMMUNITY PHARMACIES
Ah_G~ lom,~,~Ba kket_&2,~onkem Starting in January 1993 all drugs marketed in Europe must have detailed written product information on either a user leaflet or the drug packaging. As several studies raise serious concern about patients' understanding of written drug information, verbally given information is needed to explain the standardized written drug information. In order to analyse the frequency and contents of the currently given verbal drug information, we collected 200 hours of audiotaped patient contacts in 20 Dutch community pharmacies. The results revealed that in 34.9% of the observed prescription drugs deliveries (n=3662) and in 30.3% of the observed OTC-deliveries (n=773) verbal drug information was given to the patient. This information consisted mainly of drug dosage instructions (prescription drugs) and product advice (OTC's), while 75% of the delivered drug information was given without patients' questioning.
The observed one-way communication with patients in these pharmacies limits the possibilities to prevent medication errors which are based upon patients' misunderstanding of written drug information. Pharmacists therefore should stimulate a two-side directed communication by inviting patients explicitly to ask their drug related questions about drug labels and leaflets in the pharmacy. A total of 223 questionnaires were despatched and the response rate was 75%. It was found that only 55% of respondents could recall having received a bulletin from the DI Centre, however, 95% of these GPs found the bulletins to be of interest. Diabetes and warfarin bulletins had both been received by 36% of GPs, whilst 78% had received a head lice publication. Disappointingly, only 43% of GPs who had received a bulletin associated it with the Welsh DI Service. When asked about future publications, the majority (73%) of respondents wanted information to be presented in a newsletter format, the preference being for short, concise publications. Forty percent of GPs responding expressed a wish to recieve DI publications quarterly. The most popular subjects requested for inelozion in any future DI publications were the cardiovascular system (45%) and skin (32%). Twenty-one percent of the GPs surveyed envisaged their DI requirements changing over the ensuing 18 months, with particular emphasis being placed upon matters relating to costs. The study revealed that present active D[ services such as bulletins are well received by GPs, however, it appears that the distribution and presentation of the information could be improved. The results of the study will allow future developments in the provision of active information to be more closely tailored to the changing requirements of GPs in Wales. 
THE ROLE OF COMMUNITY PHARMACIES IN DRUG INFORMATION TO HEALTH PERSONNEL
Drug information towards doctors is dominated by the pharmaceutical industry. The Norwegian Health Authorities want to strengthen information from other sources to obtain a rational use of drugs. As a consequence of the Norwegian approach to the EEC, the number of registered pharmaceutical specialities will increase. At the same time the marketing of drugs may become more aggressive. The need for information about new drugs and drug therapy will increase. The Health Authorities outline a drug information network based on three levels: 1) Norwegian Medicines Control Authority, University Institutes, etc.
2) Regional Drug Information Centres 3) Local Primary Health Care and local pharmacies
The local level is important in improving the quality of drug prescribing and patient care. The community pharmacies could play a role in drug information to other health care professionals, placing drug therapy on the agenda, pass on experience and questions from the local level to higher levels, ensure appropriate prescribing at the primary care and secondary care interface.
The Norwegian Association of Proprietor Pharmacists for this reason have discussed the role of our association and the pharmacies in a drug information network.
A report concludes:
the pharmacies should be involved in drug committees and other local joint activities.
disseminating information to the medical profession in meetings and office visits on new drugs and their role in therapy, initiating therapy decisions.
developing prescription statistics as a valuable tool.
establish two pilot projects to gather experience on this kind of work.
The Norwegian Association of Proprietor Pharmacists, P.O. Box 5070, Majorstua, N-0301 Os/o, Norway.
SUPPORT OF DUTCH PHARMACISTS BY PHAKMA SELECTA

LW. Foppe van Mil_
The Dutch governement has been looking for a means to influence prescribing doctors. A system of regular pharrnacotherapeutic consultation has recently been organised, called the Farmaco Therapeutiseh Overleg (FRO).
Groups of general practitioners meet with retail pharmacists to discum rational pharmacotherapy, ususslly every 8 weeks. Dutch pharmacist also give more and more information about medicines to the patient. In both cases they need sources to turn to for their pharmacotherapeutic information. A Drug Bulletin and a literature database were developed for this purpose by a independent foundation of pharmacists, called Pharma Selecta. In this lecture the development of the database will be described.
Items like purpose, history, choice of sources, the structure and the recent developments in the marketing of the database will be discussed. A sample of the database will be presented for demonstration.
Zuidlaarder Apotheek, Kerkstraat 2, 9471 GB Zuidlaren, The Netherlands. DEVELOPMENT AND USE OF THE "GRONINGER FORMULARIUM"
I.W. Timm~
In the region of Groningen, a Province in the Northern part of The Netherlands, a drug-formulary has been in use since 1991. The formulary is principally meant for general practitioners (GPs), pharmacists and specialists in the Groningen area. The basis for this formulary is laid by a local formulary from a health-care centre with regular consultation between pharmacists and GPs. The development from a local to a regional formulary will be described.
Recently a survey was held among GPs in the area, and the results show that the formulary is accepted as a resource for daily prescribing. Half of the GPs consult the booklet more than once a week and 80% of them use it for the choice of drugs.
The use of the formulary is stimulated by discu~ing it in local pharmacotherapy consultation groups of GPs and pharmacists. However, a discussion of the formulary in this way is not a necessary condition for frequent use. A considerable number of GPs use it frequently, but do not discuss it in their pharmacotherapy consultation.
Neither is influence on the contents a necessary condition for frequent use and, accordingly, for acceptance of the formulary. Another way to stimulate the use of it is by putting relevant practical information about a drug in the formulary, like dosage, relevant side effects etc.
This information must be carefully selected on the importance for treatment of the patient~
CUSTOMER APPLICATIONS OF THE EMSCOPES SERVICES
AnnetteA-lerholdt
More and more information services today require customised information in order to meet user needs more accurately and in a more timely manner. The Excerpta Medics SDI Service (Selective Dissemination of Information), one of several EMSCOPES Services, offers customers several different products, tailored in many different ways to meet customer-specific needs. The various manifestations of these products are used in many different, often unique, ways by the purchasing information services. The paper groups these into broad types, and discusses individual examples for each.
Advantages and disadvantages for each are given, and further practical applications and uses for data received via these products are described.
Excerpts Medics, 9 Astor Close, Kingston, Surrey KT2 7LT, England.
Apotheek Lewenborg, Kombuis 173, 9732 GK Groningen, The Netherlands.
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D9 INVENTORY 1993 OF THE EUROPEAN PHARMACEUTICAL AUDIT OF THE SPECIALIST FILE ON DRUGS IN LIVER DISEASE PERIODICALS P~Bado ~rLA._P_icardL~P~Belbenoit2+ F. Loche OrLL&~I_Grossct-g3range2
Pharmaceutical periodicals represent one of the most important ways of pharmaceutical information provision. In order to know better this irreplaceable way of information, we made an inventory of the 1993 current pharmaceutical periodicals regularly published at least twice a year within geographic Europe. These periodicals publish papers intended to help, inform and train pharmacists working in community, industry hospitals or research; those exclusively dealing with homoeopathy cosmetology, toxicology or pharmacognosy were excluded. Our methodology led us to consult many information sources; the Ulrich's International Periodical Directory 1990, the Serial Directory EBSCO 1991, the database Serline from NLM (National Library of Medicine), the French Collective Directory (CCN), the lists of the American Society of Hospital Pharmacy and the international subscription office Dawson. The lists of international bibliographic systems such as Index Medicus, Biological Abstracts, Chemical Abstracts, Excerpta Medica, International Pharmaceutical Abstracts, Current Contents were also consulted. Moreover, letters were mailed to many European Drug Information Centres in order to have information about the periodicals to which they subscribed. Our survey was supplemented by mailing a questionnaire to the editors. Then, we made a database on a Macintosh computer with the software 4e Dimension. The results are as follows: 1) 314 periodicals from 29 countries were found 2) 135 scientific, 39 professional, 64 scientific and professional periodicals 3) periodicals are mainly published in the United Kingdom (61), France (60), Germany (44) 4) the distribution level is international (126), national (109) 5) the main languages are English (163), French (66), German (39) 6) the frequency is weekly (9), bi-weekly (6), monthly (86), bi-monthly (74), quarterly (87). Otherwise, the 30 independent bulletins were specially studied. At the end of the work which was as exhaustive as possible, a database makes it possible to have an overview of the characteristics of the European pharmaceutical periodicals. The audit data indicates that 88% of respondents found the service 'helpful', and 79~ were satisfied with response times. However, 58% could not provide extra clinica data due to the loss of patients to follow-up or lack of access to the clinical team There have been several practical benefits associated with this audit, such as revisec enquiry answering procedures and specific research conducted for enquiries wit} apparently unsatisfactory responses. As a result, auditing is now carried out routineI) for all enquiries received. (adverse effects, drug evaluation, pregnancy, reviews, etc). This represents some 400-500 enstomer contacts each month in addition to help with educational courses, etc. A scoring sys!em devised by Mike Spencer is currently being used to rate the importance of some of the enquiries. At the same time, the potential for additional health care resource consumption should the advice given not be followed is also being explored in an attempt to start evaluating the cost-effectiveness of DI services.
Where possible, we are also trying to ascertain whether the advise was acted upon.
The preliminary results will be presented at this meeting. Verona, Italy.
QUALITY ASSURANCE PROGRAMME BY COMPUTER OF THE PASSIVE INFORMATION IN A DRUG INFORMATION CENTRE
Sara_Erias
The Drug Information Centre of the Official Council of Pharmacists of Madrid have had 40,000 queries a year in the last years. We are three pharmacists working full-time and this number of queries makes us work too fast and we need a computer system and an internal file system to be able to recover fast information when the query is repeated. We created a computer system trying to do a quality assurance of our queries and answers. We work with five variables:
1) Who makes the query: Hospital Pharmacist, Community Pharmacist, Physician, etc. We have 9 different types.
2) What is the query about: we have 13 different types with several sub-types.
3) Who prepares the answer: We are three pharmacists. 4) How much time do we spend in answering: l:less that one hour, 2:less that 24 hours, 3:more than 24 hours. 5) How many books or computer systems we need to use. The eighth module will deal with pharmaeokinetics.
INFORMATION ABOUT SIDE EFFECTS OF DRUGS IN THERIAQUE,
All the side effects linked to drug administration at the usual therapeutic dose, or in ease of overdosage, are described through several parameters: the nature of the side effect, belonging to a thesaurus organised into a hierarchy, the frequency, the circun~tances of it arising, and the management.
Side effects are assigned to a pharmacological or a chemical class, or specifically to a drug.
All this information is coded. Free texts including some details and bibliographic references are added to each information sheet.
The validation includes the choice of the sources of information, the procedures for selecting and entering data, and the entered data. It has been provided by a groups of hospital pharmacists and by some French Pharmacovigilance centres.
Centre National d'lnformation sur le M~dicament Hospitalier, CNIMH, 7 rue du Fer Moulin, 75005 Paris, France.
PROVISION OF INFORMATION IN THE PHARMACEUTICAL FIELD IN RUSSIA
Galina V. Shardakoxa
The Government of the Russian Federation, in the framework of the adopted State Programme of the RSFSR for Improvement of Drug Supply and Development of Pharmaceutical Industry in 1992-1995, envisaged establishing a system for the provision of information in the field of manufacture and sale of pharmaceuticals. This includes:
1) An information service on the activity of manufacturing plants, organisations and institutions related to the development, production, trial and sale of drugs (establishing data banks).
2) Formation of inter-departmental and inter-regional information structures related to drug supply on the territory of the Russian Federation.
3) Carrying out systematic scientific information analysis of the market situation and studying demand and supply of drugs and consumption levels.
4) Development of a unified classification and coding system for drugs.
5) Provision of information service of work for determining and establishing an optimal structure of pharmaceutical consumption under the conditions of transition to market economy relations.
6) An information service to health care specialists and the population regarding matters of drug supply.
The objectives of the Russian Centre for Pharmaceutical and Medico-Technical Information ("Pharmedinfo") include the creation of an integrated system for pharmaceutical information using modem information technology and the analysis of scientific information on the clinical pharmacology, pharmaceutical and chemical characteristics of drugs. One of the principal databases developed is the automated information retrieval system on drugs called "Lekinform".
The Centre undertakes market research and studies domestic and foreign pharmaceutical markets, carries out organisation of advertising and exhibitions, and publicity.
Russian Centre for Pharmaceutical & Medico-Technical Information ("Pharmedinfo") Ministry of Health of the Russian Federation, 101497 Moscow, GSP-4 .Pnshkinskaya st. 7, Russia.
